Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Invesco Launches China Healthcare Equity Fund

publication date: Apr 6, 2021

Invesco has launched a new China Healthcare Equity fund to offer a diversified portfolio of China-listed healthcare companies. Based in Hong Kong, the fund will take positions mainly in Shanghai and Shenzhen-listed companies that are available in Hong Kong through Stock Connect, which allows investors to trade in Mainland China listings via Hong Kong brokers. The fund intends to invest in mid-cap stocks involved in five healthcare subsectors: medical devices, CROs/CDMOs, drug companies, medical services and vaccine producers. More details....

Share this with colleagues:

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021